HOME >> BIOLOGY >> NEWS
Mutation in clams protects against paralytic shellfish poisoning but raises human health risk

Just like people, clams can be affected by the toxins that cause paralytic shellfish poisoning (PSP), but scientists have now identified a mutation in clams that gives some protection. PSP toxins interfere with nerve function, and the mutation, which changes a single amino acid in a sodium channel, makes nerves less sensitive to those toxins.

The discovery is reported in the April 7 issue of the journal Nature. The authors suggest that it has wide ranging implications for the evolution of shellfish in the presence of toxic algae and increases the risk of PSP to people who eat clams by enabling contaminated clams to survive in the presence of toxins.

The report, "Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP," was written by a team of scientists, including Laurie Connell of the University of Maine School of Marine Sciences. It describes differences in the responses of two soft shell clam populations -- one in the Bay of Fundy and the other in the Lawrencetown estuary in Nova Scotia -- to saxitoxin as well as tetrodotoxin, a powerful toxin derived from the puffer fish.

The lead author is V. Monica Bricelj of the Institute for Marine Biosciences in Halifax, Nova Scotia, and in addition to Connell, co-authors are Keiichi Konoki, Todd Scheuer, and William A. Catterall of the University of Washington; Scott P. MacQuarrie of the Institute for Marine Biosciences; and Vera L. Trainer of the National Oceanic and Atmospheric Administration in Seattle.

"Since the 1960s, it's been known that different species of shellfish have different resistance to PSP toxins," says Connell. "This is the first time the source of that resistance has been shown. We now have a marker that can be used to determine if clams have this mutation. It's easy to use and could help reduce the time of clam flat closures (related to red tide)."

Betty Twarog, a neurophysiologist who works at UMaine's Darling Marine Center in Walpole, Main
'"/>

Contact: Laurie Connell
laurie.connell@umit.maine.edu
207-581-2470
University of Maine
6-Apr-2005


Page: 1 2

Related biology news :

1. Mutation improves memory, may lead to memory-enhancing pill
2. Mutation in HNF4A associated with an increase in birthweight and macrosomia
3. Mutations point the way to new leukemia drugs
4. Mutation in tumor suppressor gene causes pancreatic islet cells to reproduce
5. Mutation in deafness gene can help heal wounds and prevent infection
6. Mutation in blood stem cells provides clues to cancer development
7. Mutation in a single gene switches a fungus-grass symbiosis from mutualistic to antagonistic
8. Mutation in brain cells of descendants of Abraham Lincoln suggest he suffered from movement disorder
9. Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs
10. Mutation may raise prostate-cancer risk in African Americans
11. Mutations in NOTCH1 gene cause aortic valve disease

Post Your Comments:
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
(Date:7/30/2015)... ... , ... Ralco is honored to announce that it is the primary sponsor ... August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where the ... their daily lives. This unique exhibit also features a birthing center for fair goers ...
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: